146 related articles for article (PubMed ID: 6204385)
21. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
[TBL] [Abstract][Full Text] [Related]
22. [Antiviral prophylaxis].
Graubner UB
Klin Padiatr; 2001 Sep; 213 Suppl 1():A69-76. PubMed ID: 11577365
[TBL] [Abstract][Full Text] [Related]
23. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial prophylaxis in bone marrow transplantation.
Momin F; Chandrasekar PH
Ann Intern Med; 1995 Aug; 123(3):205-15. PubMed ID: 7598303
[TBL] [Abstract][Full Text] [Related]
25. [Infection and protected environment].
Funada H
Rinsho Byori; 1991 Jul; Suppl 90():115-26. PubMed ID: 1920849
[No Abstract] [Full Text] [Related]
26. Infections in allogeneic bone marrow transplant recipients.
Wingard JR
Semin Oncol; 1993 Oct; 20(5 Suppl 6):80-7. PubMed ID: 8211220
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow transplantation: current perspectives and future directions.
Cheson BD; Curt GA
J Natl Cancer Inst; 1986 Jun; 76(6):1265-7. PubMed ID: 3012181
[No Abstract] [Full Text] [Related]
28. [Current therapies 1990-1995 in infectious diseases].
Scheen AJ
Rev Med Liege; 1995 Oct; 50(10):413-7. PubMed ID: 7491439
[No Abstract] [Full Text] [Related]
29. Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: effects of prophylactic measures.
Buckner CD; Clift RA; Thomas ED; Hersman J; Sanders JE; Stewart PS; Wade JC; Murphy M; Counts G; Meyers JD
Infection; 1983; 11(5):243-50. PubMed ID: 6417027
[TBL] [Abstract][Full Text] [Related]
30. [Strategies for the prevention of infection in patients in situations of defensive deficit. The system used at the Hematologic Clinical Unit of the Clinica Puerta de Hierro (U.A.M.)].
Fernández MN; Zabala P; Cabrera R; Sanjuan I; Barbolla L
Sangre (Barc); 1985; 30(4-B):515-28. PubMed ID: 3936203
[No Abstract] [Full Text] [Related]
31. Acyclovir prophylaxis of herpes-simplex-virus infections.
Saral R; Burns WH; Laskin OL; Santos GW; Lietman PS
N Engl J Med; 1981 Jul; 305(2):63-7. PubMed ID: 6264292
[TBL] [Abstract][Full Text] [Related]
32. Prevention of cytomegalovirus disease in renal allograft recipients.
Balfour HH
Scand J Infect Dis Suppl; 1991; 80():88-93. PubMed ID: 1725064
[TBL] [Abstract][Full Text] [Related]
33. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
[TBL] [Abstract][Full Text] [Related]
34. Cytomegalovirus infection after bone marrow transplantation in children.
Castagnola E; Cappelli B; Erba D; Rabagliati A; Lanino E; Dini G
Hum Immunol; 2004 May; 65(5):416-22. PubMed ID: 15172440
[TBL] [Abstract][Full Text] [Related]
35. An open trial with acyclovir for the treatment of viral infections in marrow graft recipients.
Van Lint MT; Frassoni F; Melioli G; Marmont A; Lombardi A; Bacigalupo A
Haematologica; 1983; 68(6):812-6. PubMed ID: 6321303
[No Abstract] [Full Text] [Related]
36. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
[TBL] [Abstract][Full Text] [Related]
37. Herpes simplex virus (HSV) colitis in a bone marrow transplant recipient.
Naik HR; Chandrasekar PH
Bone Marrow Transplant; 1996 Feb; 17(2):285-6. PubMed ID: 8640181
[TBL] [Abstract][Full Text] [Related]
38. Prophylactic granulocyte transfusions during human bone marrow transplantation.
Winston DJ; Ho WG; Young LS; Gale RP
Am J Med; 1980 Jun; 68(6):893-7. PubMed ID: 6247910
[TBL] [Abstract][Full Text] [Related]
39. Cytomegalovirus disease in liver transplant recipients: impact of acyclovir prophylaxis.
Kizilisik TA; Preiksaitis JK; Kneteman NM
Transplant Proc; 1993 Jun; 25(3):2282-3. PubMed ID: 8390739
[No Abstract] [Full Text] [Related]
40. Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.
Winston DJ; Ho WG; Bartoni K; Champlin RE
Bone Marrow Transplant; 1993 Sep; 12(3):283-8. PubMed ID: 8241988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
